India News | Edited by Ashutosh Tripathi | Monday June 28, 2021
Dr Reddy's Laboratories today announced the commercial launch of 2-Deoxy-D-Glucose (2-DG) used to treat Covid patients, adding that the drug will be available across hospitals in metros and Tier 1 cities in the initial weeks.
www.ndtv.com